97. Ulcerative colitis Clinical trials / Disease details
Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04775732 (ClinicalTrials.gov) | June 1, 2018 | 25/2/2021 | Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease | Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic Trial | Crohn Disease;Ulcerative Colitis | Biological: infliximab therapeutic drug monitoring | Imelda GI Clinical Research Center | NULL | Completed | N/A | N/A | All | 187 | Phase 4 | Belgium |